Ming-Swang Lok
Hematology & Oncology · San Bernardino, CANPI 1548752371
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.2% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,780 and has fallen 99.0% since, to $18 in 2025. That places this record below the midpoint for hematology & oncology clinicians in CA, where the typical reported total is $3,371.
Across 124 payments — averaging $18.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$277
- Novartis$264
- Pfizer$208
- Astellas Pharma US Inc$157
- Amgen$126
- Johnson & Johnson$125
- plus $1K from 25 others
What the payments were for
- Food & beverage$2,10594%
- Education$1316%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 18 | $277 |
| Novartis | 15 | $264 |
| Pfizer | 14 | $208 |
| Astellas Pharma US Inc | 7 | $157 |
| Amgen | 5 | $126 |
| Johnson & Johnson(2 entities) | 6 | $125 |
| Incyte Corporation | 7 | $111 |
| AbbVie | 5 | $104 |
| AstraZeneca(2 entities) | 4 | $95 |
| Bayer | 5 | $90 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $78 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $54 |
| Verastem, Inc. | 2 | $50 |
| Merck | 3 | $49 |
| AMAG Pharmaceuticals, Inc. | 2 | $46 |
| Sanofi | 2 | $42 |
| CSL Behring | 2 | $42 |
| Dendreon Pharmaceuticals LLC | 1 | $34 |
| Puma Biotechnology, Inc. | 2 | $34 |
| Boehringer Ingelheim | 2 | $32 |
| Genentech USA, Inc. | 2 | $28 |
| Secura Bio, Inc. | 4 | $27 |
| Spectrum Pharmaceuticals Inc. | 1 | $24 |
| Array Biopharma Inc | 1 | $23 |
| Exelixis Inc. | 1 | $22 |
| Eisai Inc. | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $19 |
| EUSA Pharma (US) LLC | 1 | $16 |
| Bristol Myers Squibb | 1 | $14 |
| Stemline Therapeutics Inc. | 1 | $14 |
| Agios Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$2,236 in reported general payments places this provider in the 40th percentile of 1,363 hematology & oncology providers in California.
Other hematology & oncology in San Bernardino
- Dennis SlamonLos Angeles$3.1M
- Sandra HorningStanford$2.5M
- Mohammadbagher ZiariCorona$2.5M
- George YaghmourLos Angeles$1.9M
- Robert VescioWest Hollywood$1.1M
- Kevin KellyLos Angeles$894K
- Johnny ChangEncino$884K
- Nitin RohatgiSacramento$814K
- Omid HamidSanta Monica$809K
- Catherine CoombsOrange$786K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.